CTLA4 and diabetes mellitus: Evidence from literature indicated the involvement of the CTLA-4 + 49 A/G variant in a number of diseases such as rheumatoid arthritis [36], Behcet’s disease [37], Graves’ disease [38], diabetes mellitus, thyroid diseases and colorectal cancer [39].